Fas-deficient mice (Fas lpr/lpr ) and humans have profoundly dysregulated T lymphocyte homeostasis, which manifests as an accumulation of CD4 1 and CD8 1 T cells as well as an unusual population of CD4
Introduction
The number of T cells in the peripheral lymphoid compartment is remarkably stable over time despite the continual export of thymocytes to the periphery where they undergo low-level homeostatic proliferation. The daily production of new T cells from the thymus combined with peripheral T-cell expansion would result in a continual increase in T-cell numbers if they were not balanced by the active removal of existing T cells.
The survival and homeostatic expansion of peripheral T cells require the engagement of TCR with self-peptide/ MHC and cytokine receptor-mediated signals (1) (2) (3) (4) (5) (6) (7) . Experimentally, homeostatic proliferation of T cells has been examined by transferring small numbers of T cells into irradiated or genetically lymphopenic mice. However, only a portion of polyclonal T cells proliferate following transfer to lymphopenic hosts (1, 8) . This suggests that considerable heterogeneity exists in the capacity to undergo homeostatic proliferation. Further studies have suggested that the proliferative capacity of a specific T cell is determined by the TCR affinity for self-peptide/MHC complexes as well as the avidity or density of self-peptide/MHC complexes (9, 10) . This is supported by studies using TCR transgenic T cells whose proliferation rate varies considerably among T cells expressing different TCR (1, 2, 7, (11) (12) (13) . For example, OT-I CD8 + T cells proliferated robustly following adoptive transfer into syngeneic lymphopenic recipients, whereas proliferation of H-Y CD8 + T cells was minimal (1, 2, 14) . In addition, some TCRs have been shown to interact with a broad spectrum of self-peptide/MHC complexes, including both MHC class I and class II, thereby enhancing the number of complexes that can provide proliferative signals (15) (16) (17) (18) (19) .
The factors that limit the homeostatic expansion of peripheral T cells have not been well characterized. It has been suggested that T-cell expansion in lymphopenic recipients may be restricted by competition for limiting resources, including IL-7 and access to antigen-presenting cells bearing appropriate self-peptide/MHC (1, (20) (21) (22) . However, a significant portion of transferred T cells continues to proliferate as measured by 5-bromo-2-deoxyuridine (BrdU) incorporation even after stable numbers of T cells have been achieved (23, 24) . This suggests that it is not entirely limitations of proliferation but also active cell death that prevents further increase in T-cell number.
The death receptor, Fas, has a prominent role in the regulation of the expansion of peripheral T cells in response to self-peptide/MHC during T-cell homeostasis. We have previously observed that T cells undergoing lymphopeniainduced proliferation express Fas and are sensitive to Fasmediated cell death (23) . Following transfer into lymphopenic hosts, Fas-deficient T cells accumulated to substantially greater numbers compared with wild-type Fas + T cells, despite equivalent rates of cell cycle entry (23) . Thus, proliferation to self-antigen/MHC, like foreign antigen-driven proliferation, is regulated by active cell death.
Fas-deficient lpr (Fas lpr/lpr ) mice manifest a profound agedependent lymphadenopathy that includes both CD44 high CD4
+ and CD44 high CD8 + T cells as well as an unusual population of polyclonal CD4
2 CD8 À TCRab + T cells that express the B-cell isoform of CD45, CD45R (B220), and lack NK1.1 (25) . Although the Fas lpr/lpr genotype was originally identified over 18 years ago as a retroposon disruption of the fas gene (26) , the source and explanation for the agedependent lymphadenopathy in Fas lpr/lpr mice have remained en enigma for many years. Little, if any, significant defect in thymic negative selection has been identified in Fas lpr/lpr mice based on deletion by endogenous or exogenous superantigens (27) (28) (29) (30) (31) (32) . Whereas Fas regulates antigen-mediated deletion in vitro, most studies support the view that there is little delay in deletion of Fas lpr/lpr T cells in response to antigens administered as exogenous proteins or following acute infections (33) (34) (35) . However, Fas does contribute to the deletion of T cells during chronic infections (33, 36) . The phenotype of Fas lpr/lpr T cells differs from that of T cells stimulated by exogenous or cognate antigen and bears a striking resemblance to T cells undergoing lymphopeniainduced proliferation, which are also CD44 high CD25 À CD69 À (13, 37) . Collectively, these observations support the view that the pronounced lymphadenopathy and phenotype of Fas lpr/lpr T cells are more likely driven by self-antigens during homeostatic proliferation than by foreign antigens. This is consistent with earlier findings that Fas lpr/lpr mice raised under germ-free and antigen-free conditions still develop lymphadenopathy (38) and that a substantial proportion of T cells in Fas lpr/lpr mice cycle in a 24-h period even in the absence of foreign antigen stimulation (23) .
Little is known regarding what distinguishes the subset of T cells that is preserved in the absence of Fas. The accumulating Fas lpr/lpr T cells are clearly polyclonal and studies of their TCR-Vb repertoire have revealed only subtle shifts from wild-type T cells (25, 39 (49) . OT-I mice were maintained by breeding transgenic TCR heterozygotes with wild-type C57BL/6 mice. Offspring were screened for clonotype TCR expression on peripheral blood lymphocytes (PBL) by flow cytometry using anti-Va2 mAb. Breeding of OT-I mice with C57BL/6 Fas lpr/lpr mice generated OT-I Fas lpr/lpr mice. Offspring were screened for the lpr mutation by PCR as described previously (46) To measure in vivo proliferation, mice received four intraperitoneal injections of 1 mg BrdU (100 ll of 10 mg ml
À1
BrdU in sterile PBS) (Sigma, St Louis, MO, USA) during the 24 h prior to tissue harvest. Three injections were given on the day prior to tissue harvest and one injection on the day of sacrifice 1 hour prior to tissue harvest.
Reagents and antibodies
The following mAbs to murine cell surface molecules were purchased from Invitrogen/Caltag Laboratories (Carlsbad, CA, USA): PE-conjugated CD45R (B220), FITC-conjugated CD44, PE-conjugated CD44, TRI-COLOR-conjugated CD4, TRI-COLOR-conjugated CD8a, PE-Cy5.5-conjugated CD4, PE-Cy5. 5 Staining for DNA-incorporated BrdU was performed using a modification of a previously described method (23, 51) . Single-cell suspensions from BrdU-pulsed mice were stained for TCRb, CD4 and CD8 expression using antibodies in PBS/ 1% BSA for 30 min at 4°C and then washed with cold (4°C) PBS. The cells were fixed for 30 min on ice following the addition of 350 ll 70% ethanol (À20°C) while gently vortexing. The cells were washed twice with cold PBS, pelleted by spinning at 10 000 3 g and fixed with 350 ll 1% methanol-free formaldehyde for 15 min on ice. The cells were permeablized in 500 ll PBS containing 1% methanolfree formaldehyde and 0.01% Tween 20 overnight at 4°C. After washing twice with cold PBS, the cells were incubated with 50 Kunitz units of DNase I (Sigma) in 0.15 M NaCl (pH = 5) containing 4.2 mM MgCl 2 for 15 min at 37°C (1 ml of 50 U ml À1 ). The cells were washed twice with cold PBS/1% BSA and incubated with anti-BrdU FITC (BD Biosciences) in 100 ll PBS/1% BSA for 30 min on ice. After washing twice with PBS/1% BSA, the cells were fixed in 1% methanol-free formaldehyde in PBS/1% BSA and stored at 4°C until analysis.
Apoptotic cell death was examined by terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nickend labeling (TUNEL) (23) . Briefly, cells were incubated with unconjugated rat and hamster IgG, stained for expression of cell surface molecules and then fixed with 1% methanol-free
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formaldehyde followed by 70% ethanol. After washing, the TUNEL reaction was performed by incubating cells in 50 ll of reaction mix containing 10 U of terminal deoxribosyl transferase (TdT), 2.5 mM cobalt chloride in 13 TdT buffer (Roche, Indianapolis, IN, USA) and 0.2 pmol ll À1 of FITCdUTP (Roche) in sterile distilled water for 1 h at 37°C. The cells were washed twice and fixed in 1% methanol-free formaldehyde. Murine thymocytes were included as a positive control for apoptotic cells.
Results

OT-I Fas
lpr/lpr mice manifest an increased CD4 + :CD8 + T-cell ratio with age OT-I mice bear a transgenic TCR (Va2 and Vb5) that recognizes chicken ovalbumin peptide 257-264 SIINFEKL restricted to MHC class I H-2K b and, as such, T lymphocytes preferentially select on class I to become CD8 + T cells (49) . OT-I mice bred onto the Fas-deficient (Fas lpr/lpr ) background did not manifest the age-dependent lymphadenopathy characteristic of non-TCR transgenic Fas lpr/lpr mice. Lymph node T cells of OT-I and OT-I Fas lpr/lpr mice contained predominantly CD8 + T cells, and nearly, all the CD8 + T cells expressed the clonotypic Va2 TCR (Fig. 1A) . However, CD8
+ Va2 + T cells from OT-I Fas lpr/lpr mice contained a higher proportion of CD44 high cells relative to OT-I mice. In addition, both OT-I and OT-I Fas lpr/lpr lymph nodes also contained a small percentage of CD4 + T cells of which approximately 40% expressed Va2, while the remainder expressed an endogenous Va. Interestingly, an increased proportion of CD4 + T cells expressed high levels of CD44 compared with CD8 + T cells in both OT-I and OT-I Fas lpr/lpr mice (Fig. 1A ). Since the mice were not intentionally challenged with any antigen, this suggested that OT-I CD4 + T cells might undergo a high rate of cell cycling in response to self-antigen/MHC. BrdU incorporation was used to determine the fraction of T cells that underwent cell cycling in vivo during a 24-h labeling period in the absence of any known foreign antigen. As anticipated, an increased proportion of CD4 + T cells (15%) incorporated BrdU compared with CD8 + T cells (4%) in both OT-I and OT-I Fas lpr/lpr mice (Fig. 1B) . BrdU incorporation was also similar between Va2
+ and Va2 2 CD4 + T cells and between OT-I and OT-I Fas lpr/lpr CD4 + T cells. We have previously shown that T cells cycling in response to stimulation by self-peptide/ MHC are sensitive to Fas-mediated cell death (23) . To measure cell death, freshly isolated lymph node T cells were cultured in the presence of cross-linked Fas ligand and then analyzed by TUNEL staining. On average, 30% of OT-I CD4 + T cells and 45% of OT-I CD8 + T cells were undergoing apoptosis (Fig. 1C ). There was a low level of spontaneous death in untreated cultures and this was not increased in OT-I Fas lpr/lpr T cells (data not shown). Thus, OT-I CD8 + T cells manifested decreased cell cycling and increased sensitivity to Fas-mediated cells death compared with OT-I CD4 + T cells.
There were, however, differences in the composition of the T-cell compartment between OT-I and OT-I Fas lpr/lpr mice with age that provided insight into the nature of the T cells that accumulate in Fas lpr/lpr mice. The increased BrdU incorporation of OT-I and OT-I Fas lpr/lpr CD4 + T cells suggested that the proportion of CD4 + T cells in OT-I mice might change with age. The number of CD8 + and CD4 + T cells in the lymph nodes of OT-I and OT-I Fas lpr/lpr mice was similar at 5 weeks of age ( Fig. 2A and B) . However, by 13 weeks of age, lymph nodes from OT-I Fas lpr/lpr mice contained a decreased number of CD8 + T cells and an increased number of CD4 + T cells. This resulted in a 4.6-fold increase in the number of CD4 + T cells relative to CD8 + T cells in OT-I Fas lpr/lpr mice from 5 (1:37) to 13 weeks (1:8) (Fig. 2D) . In contrast, the number of CD4 + and CD8 + T cells in OT-I mice remained constant with age. Moreover, 13-week-old OT-I Fas lpr/lpr mice had a modest increase in the number of (Fig. 2C ). The increase in the proportion of CD4
+ to CD8 + T cells in OT-I Fas lpr/lpr mice suggested 
OT-I CD4 + T cells preferentially expand during lymphopeniainduced proliferation
The high rate of proliferation of OT-I CD4 + T cells in the absence of administered antigen suggested that this subset either underwent rapid proliferation to self-antigen or had an intrinsically increased survival rate compared with OT-I CD8 + T cells. To further explore these possibilities, we used the experimental model of lymphopenia-induced proliferation by adoptively transferring OT-I and OT-I Fas lpr/lpr lymph node cells into syngeneic Rag1 o/o hosts and analyzed the number and phenotype of the donor T cells analyzed 14 days after transfer. The ratio of CD4 + :CD8 + T cells recovered from the recipients on day 14 post-transfer revealed a dramatic increase in CD4 + T cells (Fig. 3A) . Donor OT-I T cells contained a CD4
+ :CD8 + ratio of only 1:13, whereas the OT-I T cells that had undergone 14 days of lymphopenia-induced proliferation manifested a CD4
+ :CD8 + T-cell ratio that had increased substantially to 1:1.5. Similarly, the ratio of CD4 (Fig. 3B) . Thus, OT-I CD4 + T cells entered the cell cycle considerably less rapidly than OT-I CD8 + T cells. BrdU incorporation was used to determine if this pattern of cell cycling continued at later time points when the cells had proliferated beyond the number of cycles detectable by CFSE labeling. In mice that received BrdU from days 13 to 14 post-transfer, on average, 40% of the CD4 + T cells from both OT-I and OT-I Fas lpr/lpr mice were BrdU + following the 24-h labeling period (Fig. 3C) . By contrast, only about 12% of the CD8 + T cells were BrdU + following the same 24-h period. This pattern of BrdU incorporation paralleled that seen in intact OT-I and OT-I Fas lpr/lpr mice (Fig. 1B) . Although the disparate cycling results from CFSE versus BrdU analysis could result from a sudden increase in the rate of cell cycle entry by OT-I CD4 + T cells at later time points, it more likely represented an increased survival of the OT-I CD4 + T-cell subset compared with OT-I CD8 + T cells. Hence, despite the increased selection of OT-I CD8 + T cells during thymic development, there was nonetheless a greater homeostatic expansion and accumulation of OT-I Fas unpublished observations). OT-I Fas lpr/lpr lymph nodes, however, contained a modestly increased proportion of CD4 2 CD8 À Va2 + T cells compared with OT-I lymph node cells (Fig. 2C) (Fig. 4A) . There was no difference in CD5 expression between OT-I and OT-I Fas lpr/lpr CD8 + T cells (Fig. 4B) scid mice. Since increased cell numbers could result from more rapid proliferation, we first analyzed the initiation of cell cycling following adoptive transfer of CFSE-labeled lymph node cells. Entry into cell cycle was equivalent on day 3 between OT-I and OT-I Fas lpr/lpr CD8 + T cells in scid mice (Fig. 5A) . Their cell cycle rates were also similar in + T cells and these CD8 + T cells expressed almost exclusively the Va2 transgene (Fig. 6A) (Fig. 6C) . There was no difference in the CD5 expression on (Fig. 6D) (Fig. 8C) . These data suggested that there is a higher rate of conversation of CD8 + T cells to CD4 T cells compared with wild-type Fas + T cells in vivo following activation by a single dose of antigen or following acute infection (33) (34) (35) 55) . However, Fas does contribute to the deletion of T cells during chronic infections (33) . Yet no increase in lymphadenopathy was reported in any of the studies using chronic infection models. We have observed that Fas-deficient T cells undergoing lymphopenia-induced proliferation accumulate to higher numbers compared with wild-type Fas + T cells despite equivalent rates of cell cycle entry (23) Peripheral T-cell homeostatic expansion and survival require TCR signals and are dependent on self-peptide/ MHC availability (1) (2) (3) (4) (5) (6) (7) . Competition between T cells for existing MHC complexes may limit T-cell survival, thereby modifying the peripheral T-cell repertoire (1, (20) (21) (22) . Although most TCR-ab recognizes peptides in the context of either MHC class I or class II, studies have shown that certain TCR can respond to multiple MHC class I and class II molecules. For example, T cells bearing OT-I, H-Y, 2C, HA and AND transgenic TCR have been shown to interact with both MHC class I and class II complexes (15) (16) (17) (18) . Since T-cell survival depends on the availability of self-peptide/MHC complexes, the capacity of a given TCR to interact with a spectrum of MHC complexes increases the likelihood of a T cell receiving the needed TCR survival signals. However, the same TCR structural limitations that result in decreased affinity for a given peptide/MHC complex may also result in ability to interact with a broader subset of self-peptides/MHC through degeneracy in recognition of conserved MHC motifs. Thus, the Fas-dependent removal of T cells that proliferate in response to low-avidity interactions with a given self-peptide/ MHC may be critical for limiting the degree of TCR promiscuity. A potential undesirable effect of such TCR promiscuity is the increased risk of autoimmune sequelae. This may explain the need for a death receptor such as Fas to remove T cells interacting chronically but with low avidity to self-peptide/ MHC complexes. 
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